Inspection Interviews in Pharmacovigilance

A practical guide to pharmacovigilance inspection interviews, interview preparation, inspector expectations and common interview mistakes.

Inspection Interviews in Pharmacovigilance

Introduction

For many pharmacovigilance professionals, inspection interviews are among the most stressful parts of a regulatory inspection.

Documents can be reviewed in advance.

Metrics can be prepared.

Reports can be organised.

Interviews are different.

They require individuals to demonstrate:

in real time.

Importantly, inspectors are rarely assessing memory.

They are assessing whether individuals understand their responsibilities and can demonstrate effective control of the pharmacovigilance system.

A useful principle is:

Inspection interviews evaluate understanding, not memorisation.

Why Inspectors Conduct Interviews

Interviews provide information that documents alone cannot.

Inspectors use interviews to:

Interviews often help inspectors determine whether processes operate as described.

What Inspectors Are Trying to Determine

Although questions vary, inspectors commonly seek answers to a small number of core questions.

Does the Individual Understand Their Role?

Are Responsibilities Clearly Defined?

Are Risks Visible?

Are Escalation Processes Effective?

Does Operational Reality Match Documentation?

Most interview questions ultimately support one or more of these objectives.

Who Gets Interviewed?

Interviewees commonly include:

QPPVs

Deputy QPPVs

Pharmacovigilance Managers

Safety Scientists

Vendor Managers

Quality Personnel

Regulatory Affairs Personnel

Medical Information Personnel

The exact selection depends upon inspection scope.

The QPPV Interview

The QPPV interview is often one of the most important inspection discussions.

Inspectors frequently explore:

The objective is generally to understand how the QPPV maintains oversight.

Common QPPV Questions

Examples include:

How is your pharmacovigilance system organised?

What are the most significant risks currently facing the system?

How do you oversee outsourced activities?

How do you monitor compliance?

How do significant issues reach your attention?

How do you know the system is working effectively?

Notice that these questions focus on oversight rather than operational details.

Vendor Oversight Questions

Vendor oversight remains a major inspection focus.

Questions may include:

Which vendors perform critical pharmacovigilance activities?

How are vendors monitored?

How are vendor risks assessed?

When was the last vendor audit performed?

How are vendor CAPAs tracked?

Inspectors often evaluate whether outsourced activities remain under effective control.

Audit and CAPA Questions

Inspectors frequently explore assurance activities.

Examples include:

How are audit plans developed?

How are risks prioritised?

How are findings classified?

How are CAPAs monitored?

How do you assess effectiveness?

The quality of responses often reflects governance maturity.

PSMF Questions

Common discussion areas include:

How is the PSMF maintained?

How frequently is it reviewed?

How are organisational changes reflected?

How are vendors incorporated?

Inspectors often compare interview responses against PSMF content.

Consistency is important.

Interview Preparation

Effective preparation focuses on understanding rather than rehearsing scripts.

Preparation activities may include:

The goal is confidence and clarity.

Understanding Your Responsibilities

One of the most common interview weaknesses occurs when individuals cannot clearly explain:

Every interviewee should understand:

Understanding Governance

Inspectors frequently explore governance arrangements.

Examples include:

Interviewees should understand how decisions are made and how issues are escalated.

Understanding Current Risks

Interviewees should generally understand:

Inspectors often view awareness of risk as evidence of effective oversight.

During the Interview

Several principles help improve interview quality.

Listen Carefully

Understand the question before answering.

Answer the Question Asked

Avoid unnecessary information.

Be Clear

Simple explanations are often most effective.

Be Accurate

Accuracy is more important than speed.

Remain Professional

Maintain a calm and respectful approach.

These behaviours support effective communication.

When You Do Not Know the Answer

One of the most important interview skills is handling uncertainty appropriately.

A useful response may be:

I would like to verify that information before responding.

Inspectors generally prefer accurate information delivered later rather than incorrect information delivered immediately.

Guessing creates unnecessary risk.

Common Interview Mistakes

Several weaknesses occur repeatedly.

Guessing

Creates inconsistencies.

Over-Answering

Introduces unnecessary risk.

Contradicting Documentation

Damages credibility.

Becoming Defensive

Reduces effectiveness.

Speculating

Creates confusion.

Blaming Others

Suggests weak ownership.

These mistakes frequently create avoidable concerns.

Consistency Matters

Inspectors often compare:

Consistency across these sources increases confidence.

Inconsistencies frequently trigger additional questions.

A useful principle is:

Consistency builds credibility.

Difficult Questions

Some questions may focus on:

Strong responses generally:

Inspectors are often interested in organisational learning rather than perfection.

Mock Interviews

Many organisations perform mock inspection interviews.

Potential benefits include:

Mock interviews can be particularly valuable for QPPVs and senior pharmacovigilance personnel.

What Strong Interviewees Demonstrate

Strong interviewees typically demonstrate:

Understanding

Ownership

Awareness

Clarity

Credibility

Risk Awareness

Governance Knowledge

These characteristics often influence inspector confidence significantly.

What Inspectors Remember

Inspectors may not remember every answer.

They often remember:

This reinforces an important point:

Interviews are assessments of control and oversight, not memory tests.

Key Takeaways

References

  1. EMA Good Pharmacovigilance Practices (GVP) Module III – Pharmacovigilance Inspections.
  2. EMA Good Pharmacovigilance Practices (GVP) Module I – Pharmacovigilance Systems and Their Quality Systems.
  3. EMA Good Pharmacovigilance Practices (GVP) Module II – Pharmacovigilance System Master File.
  4. Regulation (EC) No 726/2004.
  5. Directive 2001/83/EC.
  6. Commission Implementing Regulation (EU) No 520/2012.
  7. ICH Q9 Quality Risk Management.
  8. ICH Q10 Pharmaceutical Quality System.
  9. PIC/S Guidance on Pharmacovigilance Inspections.

Last reviewed: 2026-06-11